🇺🇸 FDA

Intelligence · Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe — grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≤24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months — use filters for patent-cliff planning.

Page 42 of 78

  1. US 8748460

    Iminosugars and methods of treating togaviral diseases

    Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8748608

    4-phenylpiperazine derivatives with functionalized linkers as dopamine D3 receptor selective ligands and methods of use

    Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8748657

    Process to prepare treprostinil

    Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8741309

    Porcine reproductive and respiratory syndrome vaccine based on isolate JA-142

    Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8741649

    Methods for enhancing genome stability and telomere elongation in embryonic stem cells

    Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8741313

    Polypeptide vaccine and vaccination strategy against mycobacterium

    Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8741869

    Oligodeoxynucleotide and its use to induce an immune response

    Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8741947

    Biologically active macrolides, compositions, and uses thereof

    Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8735082

    Gene signature for predicting prognosis of patients with solid tumors

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8735355

    Methods of use of fragments of secreted frizzled related protein, sFRP

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8734830

    Manufacturing method and apparatus of ultrafine particles having uniform particle size distribution

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8735407

    Purine derivatives as A3 adenosine receptor-selective agonists

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8735369

    Compositions and methods for inhibiting expression of a gene from the Ebola virus

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8735126

    Disease control with tick phospholipase A2

    Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8729053

    Nuclear factor kappa B pathway inhibitor composition and use of same

    Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8728526

    Coacervate microparticles useful for the sustained release administration of therapeutic agents

    Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8728488

    Methods of inducing an immune response in a host by administering flavivirus immunogens comprising extracellular viral particles composed of the premembrane (prM) and envelope (E) antigens

    Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8722653

    Method for treating uterine fibroids

    Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8722063

    Vaccination of animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission

    Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8722046

    Human monoclonal antibodies protective against bubonic plague

    Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8715591

    Microfluidic apparatus to control liposome formation

    Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8715751

    Artemisinins in the clinical and veterinary management of kinetoplastid infections

    Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8715686

    Conformationally stabilized HIV envelope immunogens

    Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8715689

    Chimeric west nile/dengue viruses

    Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8715949

    Applications of the binding interaction of proanthocyanidins with bacteria and bacterial components

    Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8716301

    Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

    Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8716315

    Analogs of thalidomide as potential angiogenesis inhibitors

    Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8716460

    Pseudomonas AVR and HOP proteins, their encoding nucleic acids, and use thereof

    Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8710026

    MiR 204, miR 211, their anti-miRs, and therapeutic uses of same

    Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8709813

    DNA promoters and anthrax vaccines

    Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8709487

    Nanoparticle entrapment of materials

    Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8710185

    Bacterial superantigen vaccines

    Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8703826

    Preparation of (R,R)-fenoterol and (R,R)-or (R,S)-fenoterol analogues and their use in treating congestive heart failure

    Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8703150

    Methods of using Bacillus anthracis protective antigen sequences for vaccination

    Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8703921

    Compositions and methods for delivering inhibitory oligonucleotides

    Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8703096

    Beta-amyloid PET imaging agents

    Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8703762

    Method of treating organophosphorous poisoning

    Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8697046

    Methods of administering interferon gamma to absorb fluid from the subretinal space

    Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8697666

    Anti-cancer oligodeoxynucleotides

    Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8697856

    Plasmodium vivax hybrid circumsporozoite protein and vaccine

    Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8691943

    Antimicrobial activity of chicken NK-2 peptide against apicomplexan protozoa

    Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8691859

    Broad spectrum antibacterial compounds

    Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8691501

    Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

    Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8685404

    Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction

    Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8685411

    Rotavirus antigens

    Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8685416

    Compositions and methods for the treatment of cancer

    Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8685722

    Bovine adeno-associated viral (BAAV) vector and uses thereof

    Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8686016

    Schweinfurthins and uses thereof

    Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.